Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III... by Fisher, C, Dhainaut, J, Opal, S, Pribble, J, Balk, R, Slotman, G, Iberti, T, Rackow, E, Shapiro, M, Greenman, R